Different estrogen receptor β expression in distinct histologic subtypes of lung adenocarcinoma by Alì, Greta, MD, Donati, Valentina, MD, Loggini, Barbara, MD, Servadio, Adele, MD, Dell'Omodarme, Matteo, PhD, Prati, Maria Cristina, PhD, Camacci, Tiziano, BS, Lucchi, Marco, MD, Melfi, Franca, MD, Mussi, Alfredo, MD, Fontanini, Gabriella, MD

Get full text

CDC25B: relationship with angiogenesis and prognosis in non–small cell lung carcinoma by Boldrini, Laura, PhD, Gisfredi, Silvia, PhD, Ursino, Silvia, PhD, Lucchi, Marco, MD, Mussi, Alfredo, MD, Fontanini, Gabriella, MD, PhD

Get full text

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup an... by Cremolini, Chiara, MD, Loupakis, Fotios, PhD, Antoniotti, Carlotta, MD, Lupi, Cristiana, BSc, Sensi, Elisa, PhD, Lonardi, Sara, MD, Mezi, Silvia, MD, Tomasello, Gianluca, MD, Ronzoni, Monica, MD, Zaniboni, Alberto, MD, Tonini, Giuseppe, Prof, Carlomagno, Chiara, PhD, Allegrini, Giacomo, MD, Chiara, Silvana, MD, D'Amico, Mauro, MD, Granetto, Cristina, MD, Cazzaniga, Marina, MD, Boni, Luca, MD, Fontanini, Gabriella, Prof, Falcone, Alfredo, Prof

Get full text

Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial by Masi, Gianluca, Dr, Loupakis, Fotios, MD, Salvatore, Lisa, MD, Fornaro, Lorenzo, MD, Cremolini, Chiara, MD, Cupini, Samanta, MD, Ciarlo, Andrea, MD, Del Monte, Francesca, PhD, Cortesi, Enrico, MD, Amoroso, Domenico, MD, Granetto, Cristina, MD, Fontanini, Gabriella, Prof, Sensi, Elisa, MD, Lupi, Cristiana, MD, Andreuccetti, Michele, CTA, Falcone, Alfredo, MD

Get full text